Akoya Biosciences EPS Diluted (Quarterly) Insights

Akoya Biosciences Inc (AKYA)

2.14 +0.02 (+0.94%) USD | NASDAQ | Nov 22, 11:58

EPS Diluted (Quarterly) Chart

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2020. Upgrade now.

Date	Value
September 30, 2024	-0.21
June 30, 2024	-0.27
March 31, 2024	-0.48
December 31, 2023	-0.22
September 30, 2023	-0.26
June 30, 2023	-0.51
March 31, 2023	-0.49
December 31, 2022	-0.50
September 30, 2022	-0.47
June 30, 2022	-0.47

Date	Value
March 31, 2022	-0.44
December 31, 2021	-0.47
September 30, 2021	-0.31
June 30, 2021	-0.20
March 31, 2021	-0.2681
December 31, 2020	-0.2381
September 30, 2020	-0.1995
June 30, 2020	-0.21
March 31, 2020	-0.0741

Earnings per Share Definition

Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.

Read full definition.

EPS Diluted (Quarterly) Range, Past 5 Years

-0.51

Minimum

Jun 2023

-0.0741

Maximum

Mar 2020

-0.331

Average

-0.27

Median

Jun 2024

EPS Diluted (Quarterly) Benchmarks

Bruker Corp	0.27
Azenta Inc	-0.10
Harvard Bioscience Inc	-0.11
Bionano Genomics Inc	-0.52
Singular Genomics Systems Inc	-6.72

EPS Diluted (Quarterly) Related Metrics

Net Income (Quarterly)	-10.53M
Revenue (Quarterly)	18.81M
Total Expenses (Quarterly)	26.24M
Enterprise Value	145.08M
Gross Profit Margin (Quarterly)	62.32%
Profit Margin (Quarterly)	-55.98%
Earnings Yield	-55.14%
Normalized Earnings Yield	-50.39